# Dose Response and Efficacy of GW842166 in Pain

> **NCT00554762** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** GW842166X

## Key facts

- **NCT ID:** NCT00554762
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-11
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Compound terminated
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554762, "Dose Response and Efficacy of GW842166 in Pain". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00554762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*